Associate Director, Regulatory Affairs, Pulmovant Remote, US Pulmovant is a Roivant-backed clinical-stage biotechnology company developing innovative therapies for patients suffering from pulmonary diseases. Pulmovants first program, mosliciguat is designed to provide an effective, once-daily, inhaled treatment
Location: This position may be performed remotely, but requires the flexibility and willingness to travel as needed. The Opportunity Turning promising science into better treatments for epilepsy takes more than expertise. It takes ownership, sound judgment,
Praxis Precision Medicines, Inc. is seeking a senior clinical leader to drive epilepsy program strategy, oversee adult and pediatric trials, and lead regulatory submissions with health authorities. You will shape development plans, interpret data, and mentor
GondolaBio seeks an experienced toxicologist to lead nonclinical safety programs for oligonucleotide therapeutics. You will design studies, oversee CROs, and advise on regulatory submissions from IND to clinical development. You will integrate toxicology, toxicokinetics, biodistribution, immunotoxicology, and
Erascais a clinical-stage precision oncology company focused on discovering, developing and commercializing medicines for the benefit of patients with cancer. Our programs take novel approaches to shutting down one of cancer’s most commonly mutated signaling cascades,
Location: This position may be performed remotely but requires flexibility and a willingness to travel as needed. Position Summary The Associate Director, Regulatory CMC willbe responsible forthe planning, preparation, and execution of Chemistry, Manufacturing, and Controls
Associate Director/Director Pharmaceutical Development Remote - USA Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement.read on In
Select how often (in days) to receive an alert: Senior Medical Director, Clinical Development Leader- GI (Remote) Alfasigma is a privately held global healthcare company founded over 75 years ago in Italy, where it remains headquartered
Pulmovant is a Roivant-backed clinical-stage biotechnology company developing innovative therapies for patients suffering from pulmonary diseases. Pulmovant’s first program, mosliciguat is designed to provide an effective, once-daily, inhaled treatment option for patients with pulmonary hypertension (PH).
Pharmatech Associates is seeking a Regulatory Affairs Consultant to support multiple projects on a remote basis, approximately 10-20 hours per week. The role centers on developing regulatory strategies to enable successful registrations and post-approval commercialization for